DM0000: The mark consists of the word "ROCKLATAN" in lower case block letters with "ROCK" in a darker shade than "LATAN" and in between four curved bands, which create the impression of parentheses, one dark and one light curved band before "ROCKLATAN" and one light and one dark curved band after "ROCKLATAN" with the words "(NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%" beneath the word "ROCKLATAN".
GS0051: Pharmaceutical preparations for the treatment of glaucoma and hypertension
Case File Event Statements
3/9/2020 - 4 years ago
15 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDType:MAB6
3/9/2020 - 4 years ago
14 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
8/6/2019 - 5 years ago
13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
6/11/2019 - 5 years ago
12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
6/11/2019 - 5 years ago
11 - PUBLISHED FOR OPPOSITIONType:PUBO
5/22/2019 - 5 years ago
10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
5/6/2019 - 5 years ago
9 - ASSIGNED TO LIEType:ALIE
4/22/2019 - 5 years ago
8 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
4/19/2019 - 5 years ago
7 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
4/19/2019 - 5 years ago
6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
4/19/2019 - 5 years ago
5 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
4/19/2019 - 5 years ago
4 - EXAMINERS AMENDMENT -WRITTENType:CNEA
4/19/2019 - 5 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
3/1/2019 - 5 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS